Anixa Biosciences(ANIX)

超过5%股东持股披露

Anixa Biosciences(ANIX)05-04 01:35

$Anixa Biosciences(ANIX)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001493152-24-017664  Act: 34  Size: 61 KB 网页链接查看全文

持股变动声明

Anixa Biosciences(ANIX)05-02 21:25

$Anixa Biosciences(ANIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-017496  Size: 5 KB 网页链接查看全文

持股变动声明

Anixa Biosciences(ANIX)06-14 22:05

$Anixa Biosciences(ANIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-023802  Size: 4 KB 网页链接查看全文

持股变动声明

Anixa Biosciences(ANIX)06-08 00:25

$Anixa Biosciences(ANIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-023037  Size: 4 KB 网页链接查看全文

持股变动声明

Anixa Biosciences(ANIX)06-10 22:05

$Anixa Biosciences(ANIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-023295  Size: 4 KB 网页链接查看全文

季度财报

Anixa Biosciences(ANIX)06-05 05:05

$Anixa Biosciences(ANIX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-24-022573  Act: 34  Size: 4 MB 网页链接查看全文

持股变动声明

Anixa Biosciences(ANIX)06-18 21:25

$Anixa Biosciences(ANIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-024226  Size: 4 KB 网页链接查看全文

持股变动声明

Anixa Biosciences(ANIX)06-07 23:05

$Anixa Biosciences(ANIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-023023  Size: 4 KB 网页链接查看全文

当期报告

Anixa Biosciences(ANIX)05-08 20:45

$Anixa Biosciences(ANIX)$ 8-K Current report, items 1.01, 7.01, and 9.01 Accession Number: 0001493152-24-018170  Act: 34  Size: 252 KB 网页链接查看全文

持股变动声明

Anixa Biosciences(ANIX)04-10 21:55

$Anixa Biosciences(ANIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-014154  Size: 4 KB 网页链接查看全文

卵巢癌CAR-T疗法遭FDA临床搁置，Anixa股价跌18%

andrewmed2021-04-21 09:14

文章来源：“凯莱英药闻”微信公众号
4月19日，纳斯达克上市公司Anixa Biosciences宣布其与莫菲特癌症中心（MCC）共同开发的卵巢癌CAR-T疗法临床试验申请（IND）遭FDA搁置，需补充申请资料以获FDA授权开展临床试验，FDA将在30日给予更详细的答复函。
受此消息影响，Anixa Biosciences股价...查看全文

chuminhua2021-04-20 21:28

4月19日，Anixa Biosciences公司周一宣布，一项评估其卵巢癌CAR-T疗法的临床研究在被FDA要求提供更多信息后被搁置，这一消息使股价下跌了28%。该公司与Moffitt Cancer Center (MCC)共同开发该疗法，并表示已于上个月底提交了IND申请。
该自体细胞疗法是由针对卵泡刺激素（FSH）受体的工程T细胞...查看全文

冷枪手假亦真2020-08-26 00:21

$Anixa Biosciences(ANIX)$ 1.7果断抄底查看全文

LAES1682020-06-27 20:44

$Anixa Biosciences(ANIX)$ 强势，下周过前高查看全文

LAES1682020-06-27 07:43

$Anixa Biosciences(ANIX)$ 盘后刚好破2.81，下周新高可期查看全文

LAES1682020-06-27 03:30

$Anixa Biosciences(ANIX)$ 差一分钱突破查看全文

LAES1682020-06-17 03:20

$Anixa Biosciences(ANIX)$ 上车查看全文

牛唐2020-06-01 22:31

又一个一周50%的收益：$Anixa Biosciences(ANIX)$ 在1.88买入，盘前2.8卖出。 $Zoom Video通讯(ZM)$ $特斯拉(TSLA)$查看全文

chuminhua2019-12-21 15:59

12月13日，据美通社报道：一家致力于利用人体免疫系统来治疗癌症的生物技术公司Anixa Biosciences$Anixa Biosciences(ANIX)$ ，宣布将其FSHR-CAR-T疗法的IND申请延迟12个月，以对该CAR-T疗法进行进一步的基因工程改造，提升其在卵巢癌中的疗效。Anixa公司计划将原定今年底提交的IND申请延迟到2020...查看全文

牛唐2019-07-18 07:50

$Anixa Biosciences(ANIX)$ 爆发13个点，之前 $Evoke Pharma(EVOK)$ 爆发27个点，这行情是看图说话吗查看全文

$Anixa Biosciences(ANIX)$ 8-K - Current report Filed: 2019-10-24 AccNo: 0001513162-19-000221 Size: 5 MBItem 5.07: Submission of Matters to a Vote of Security HoldersItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接

$Anixa Biosciences(ANIX)$ DEF 14A - Other definitive proxy statements Filed: 2019-09-12 AccNo: 0001513162-19-000205 Size: 443 KB 网页链接

$Anixa Biosciences(ANIX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-09-06 AccNo: 0001513162-19-000202 Size: 5 MB 网页链接

$Anixa Biosciences(ANIX)$ 8-K - Current report Filed: 2019-08-27 AccNo: 0001513162-19-000191 Size: 104 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$Anixa Biosciences(ANIX)$ 8-K - Current report Filed: 2019-08-21 AccNo: 0001513162-19-000185 Size: 3 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接

$Anixa Biosciences(ANIX)$ 8-K - Current report Filed: 2019-07-18 AccNo: 0001513162-19-000164 Size: 36 KBItem 1.01: Entry into a Material Definitive Agreement 网页链接

$Anixa Biosciences(ANIX)$ EFFECT - Notice of Effectiveness Filed: 2019-06-21 AccNo: 9999999995-19-001410 Size: 1 KB 网页链接

$Anixa Biosciences(ANIX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-06-12 AccNo: 0001513162-19-000156 Size: 4 MB 网页链接

$Anixa Biosciences(ANIX)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2019-06-11 AccNo: 0001513162-19-000150 Size: 1 MB 网页链接

$Anixa Biosciences(ANIX)$ 8-K - Current report Filed: 2019-05-23 AccNo: 0001513162-19-000133 Size: 2 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接